Outlook Therapeutics, Inc.Outlook Therapeutics, Inc.Outlook Therapeutics, Inc.

Outlook Therapeutics, Inc.

No trades
See on Supercharts

Price target

7.200.000.00%
The 5 analysts offering 1 year price forecasts for OTLK have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to OTLK in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


OTLK EPS for the last quarter is −0.89 USD despite the estimation of −0.76 USD. In the next quarter EPS is expected to reach −0.61 USD. Track more of Outlook Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Outlook Therapeutics, Inc. revenue is expected to reach ‪878.25 K‬ USD. Check out Outlook Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, OTLK price target is 7.20 USD with a max estimate of 11.00 USD and a min estimate of 3.00 USD. Check if this forecast comes true in a year, meanwhile watch Outlook Therapeutics, Inc. stock price chart and keep track of the current situation with OTLK news and stock market news.
We've gathered opinions of 5 analysts rating OTLK stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.